DCECT; dogs; nasal tumor; perfusion CT; radiotherapy; Dogs; Animals; Prospective Studies; Cross-Sectional Studies; Tomography, X-Ray Computed/veterinary; Tomography, X-Ray Computed/methods; Nose Neoplasms/diagnostic imaging; Nose Neoplasms/veterinary; Carcinoma/veterinary; Sarcoma/diagnostic imaging; Sarcoma/veterinary; Adenocarcinoma/veterinary; Dog Diseases/diagnostic imaging; Adenocarcinoma; Carcinoma; Dog Diseases; Nose Neoplasms; Sarcoma; Tomography, X-Ray Computed; Veterinary (all); General Veterinary
Abstract :
[en] [en] BACKGROUND: Treatment of nasal tumors in dogs is associated with high morbidity and reliable prognostic factors are lacking. Dynamic contrast-enhanced computed tomography (DCECT) can be used to assess tumor perfusion.
OBJECTIVES: To assess perfusion parameters of nasal tumors (correlating with tumor type) before and during radiotherapy (RT) and find potential correlation with survival.
ANIMALS: Twenty-four client-owned dogs with nasal tumors, including 16 epithelial tumors and 8 sarcomas.
METHODS: Prospective cross-sectional study. All dogs had baseline DCECT to assess fractional vascular volume (BV), blood flow (BF), and transit time (TT). Thirteen dogs had repeat DCECT after 12 Gy of megavoltage RT. Survival times were calculated.
RESULTS: Median BV was 17.83 mL/100 g (range, 3.63-66.02), median BF was 122.63 mL/100 g/minute (range, 23.65-279.99), and median TT was 8.91 seconds (range, 4.57-14.23). Sarcomas had a significantly lower BF than adenocarcinomas (P = .002), carcinomas (P = .01), and other carcinomas (P = .001), and significantly lower BV than adenocarcinomas (P = .03) and other carcinomas (P = .004). Significant associations were found between epithelial tumors and sarcoma for change in tumor volume (P = .01), width (P = .004), and length (P = .02) in that epithelial tumors decreased in volume whereas sarcomas increased in volume. Perfusion parameters were not correlated with survival.
CONCLUSIONS AND CLINICAL IMPORTANCE: Nasal sarcomas have lower BV and BF than nasal carcinomas, and sarcomas have a lower size reduction than carcinomas early on during RT. Baseline results and changes in perfusion parameters may not be correlated with survival.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Mortier, Jérémy ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) ; Small Animal Teaching Hospital, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, United Kingdom
Maddox, Thomas W; Small Animal Teaching Hospital, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, United Kingdom
Blackwood, Laura; Small Animal Teaching Hospital, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, United Kingdom
La Fontaine, Matthew D; The Netherlands Cancer Institute, Amsterdam, The Netherlands
Busoni, Valeria ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée
Language :
English
Title :
Dynamic contrast-enhanced computed tomography in dogs with nasal tumors.
Funding provided by a research grant from the Université de Liège. Part of this study was presented at the Congrès d'Imagerie Vétérinaire Francophone 2019 (Bordeaux, France), at the FARAH day 2019 (Liège, Belgium) and at the EAVDI‐BID meeting 2022 (Warwick, UK).
Madewell BR, Priester WA, Gillette EL, Snyder SP. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges. Am J Vet Res. 1976;37(7):851-856.
Buchholz J, Hagen R, Leo C, et al. 3D conformal radiation therapy for palliative treatment of canine nasal tumors. Vet Radiol Ultrasound. 2009;50(6):679-683.
Mason SL, Maddox TW, Lillis SM, Blackwood L. Late presentation of canine nasal tumours in a UK referral hospital and treatment outcomes. J Small Anim Prac. 2013;54(7):347-353.
Sones E, Smith A, Schleis S, et al. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011). Vet Radiol Ultrasound. 2013;54(2):194-201.
Kubicek L, Milner R, An Q, et al. Outcomes and prognostic factors associated with canine sinonasal tumors treated with curative intent cone-based stereotactic radiosurgery (1999-2013). Vet Radiol Ultrasound. 2016;57(3):331-340.
Thrall DE, McEntee MC, Novotney C, Hauck ML, Page RL. A boost technique for irradiation of malignant canine nasal tumors. Vet Radiol Ultrasound. 1993;34(4):295-300.
Morris JS, Dunn KJ, Dobson JM, White RAS. Effects of radiotherapy alone and surgery and radiotherapy on survival of dogs with nasal tumours. J Small Anim Prac. 1994;35(11):567-573.
Tan-Coleman B, Lyons J, Lewis C, Rosenberg M, Ruiz A. Prospective evaluation of a 5 × 4 Gy prescription for palliation of canine nasal tumors. Vet Rad Ultrasound. 2013;54(1):89-92.
Glasser SA, Charney S, Dervisis NG, et al. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. J Am Anim Hosp Assoc. 2014;50(2):96-104.
Gieger TL, Nolan MW. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016). Vet Comp Oncol. 2018;16(1):68-75.
Mayer MN, DeWalt JO, Sidhu N, Mauldin GN, Waldner CL. Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011–2016). J Am Vet Med Assoc. 2019;254(5):602-612.
Fox-Alvarez S, Shiomitsu K, Lejeune AT, Szivek A, Kubicek L. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas. Vet Rad Ultrasound. 2020;61(3):370-378.
Galloway A, Lana S, Thamm D, Boss K. Outcome and metastatic behavior of canine sinonasal osteosarcoma (2005–2015). J Am Anim Hosp Assoc. 2020;56(2):98-105.
Morgan MJ, Lurie DM, Villamil AJ. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016). BMC Res Notes. 2018;11(1):1-6.
Fan VC, Mayer MN, Sukut SL, Gustafson NR, Mauldin GN, Waldner CL. Retrospective survey of owners' experiences with palliative radiation therapy for pets. J Am Vet Med Assoc. 2018;253(3):307-314.
Nguyen SM, Thamm DH, Vail DM, London CA. Response evaluation criteria for solid tumours in dogs (v1.0): A Veterinary Cooperative Oncology Group (VCOG) consensus document. Vet Comp Oncol. 2015;13(3):176-183.
Nell E, Ober C, Rendahl A, Forrest L, Lawrence J. Volumetric tumor response assessment is inefficient without overt clinical benefit compared to conventional, manual veterinary response assessment in canine nasal tumors. Vet Rad Ultrasound. 2020;61(5):592-603.
Miles KA, Lee TY, Goh V, et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol. 2012;22(7):1430-1441.
Cuenod CAA, Balvay D. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging. 2013;94(12):1187-1204.
García-Figueiras R, Goh VJ, Padhani AR, et al. CT perfusion in oncologic imaging: a useful tool? Am J Roentgenol. 2013;200(1):8-19.
Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004;14(3):198-206.
Razek AAKA, Tawfik AM, Elsorogy LGA, Soliman NY. Perfusion CT of head and neck cancer. Eur J Radiol. 2014;83(3):537-544.
Preda L, Calloni SF, Moscatelli MEM, Cossu Rocca M, Bellomi M. Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma. Biomed Res Int. 2014;2014:917150.
Petralia G, Bonello L, Viotti S, Preda L, D'Andrea G, Bellomi M. CT perfusion in oncology: how to do it. Cancer Imaging. 2010;10(1):8-19.
Troeltzsch D, Niehues SM, Fluegge T, et al. The diagnostic performance of perfusion CT in the detection of local tumor recurrence in head and neck cancer. Clin Hemorheol Microcirc. 2020;76(2):171-177.
Yoon S, Alfajaro MM, Cho KO, et al. Perfusion change in benign prostatic hyperplasia before and after castration in a canine model: contrast enhanced ultrasonography and CT perfusion study. Theriogenology. 2020;156:97-106.
Lee SK, Jang Y, Jung J w, Je H, Choi J. Comparison of renal blood flow using maximum slope-based computed tomography perfusion and ultrasound flow probe in healthy dogs. Front Vet Sci. 2020;7(October):1-8.
Kishimoto M, Tsuji Y, Katabami N, et al. Measurement of canine pancreatic perfusion using dynamic computed tomography: influence of input-output vessels on deconvolution and maximum slope methods. Eur J Radiol. 2011;77(1):175-181.
Kishimoto M, Yamada K, Seok JS, et al. Analysis of blood flow in a third ventricular ependymoma and an olfactory bulb meningioma by using perfusion computed tomography. J Vet Med Sci. 2008;70(9):981-983.
Nitzl D, Ohlerth S, Mueller-Schwandt F, Angst A, Roos M, Kaser-Hotz B. Dynamic computed tomography to measure tissue perfusion in spontaneous canine tumors. Vet Radiol Ultrasound. 2009;50(4):347-352.
Nabavi DG, Cenic A, Dool J, et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr. 1999;23(4):506-515.
Groothuis DR, Lapin GD, Vriesendorp FJ, Mikhael MA, Patlak CS. A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography. J Cereb Blood Flow Metab. 1991;11(6):939-948.
Camp S, Fisher P, Thrall DE. Dynamic CT measurement of contrast medium washin kinetics in canine nasal tumors. Vet Radiol Ultrasound. 2000;41(5):403-408.
Park S, Jung JW, Je H, Jang Y, Choi J. Effect of slice thickness on computed tomographic perfusion analysis of the pancreas in healthy dogs. Am J Vet Res. 2020;81(9):732-738.
Peterson KL, MacLeod AG, Wisner ER, Larson RF, Pollard RE. Quantitative assessment of blood volume, blood flow, and permeability of the brain of clinically normal dogs by use of dynamic contrast- enhanced computed tomography. Am J Vet Res. 2008;69(1):45-50.
Malinen E, Rødal J, Knudtsen IS, Søvik Å, Skogmo HK. Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT. Acta Oncol. 2011;50(6):873-882.
MacLeod AG, Dickinson PJ, LeCouteur RA, Higgins RJ, Pollard RE. Quantitative assessment of blood volume and permeability in cerebral mass lesions using dynamic contrast-enhanced computed tomography in the dog. Acad Radiol. 2009;16(10):1187-1195.
Hansen AE, Kristensen AT, Law I, McEvoy FJ, Kjær A, Engelholm SA. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT. Radiother Oncol. 2012;102(3):424-428.
la Fontaine MD, McDaniel LS, Kubicek LN, Chappell RJ, Forrest LJ, Jeraj R. Patient characteristics influencing the variability of distributed parameter-based models in DCE-CT kinetic analysis. Vet Comp Oncol. 2017;15(1):105-117.
Zwingenberger AL, Pollard RE, Taylor SL, Chen RX, Nunley J, Kent MS. Perfusion and volume response of canine brain tumors to stereotactic radiosurgery and radiotherapy. J Vet Intern Med. 2016;30(3):827-835.
Rødal J, Rusten E, Søvik Å, Skogmo HK, Malinen E. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncol. 2013;52(7):1293-1299.
Zwingenberger AL, Shofer FS. Dynamic computed tomographic quantitation of hepatic perfusion in dogs with and without portal vascular anomalies. Am J Vet Res. 2007;68(9):970-974.
Adams WM, Kleiter MM, Thrall DE, et al. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors. Vet Radiol Ultrasound. 2009;50(3):330-335.
Skinner OT, Boston SE, Giglio RF, Whitley EM, Colee JC, Porter EG. Diagnostic accuracy of contrast-enhanced computed tomography for assessment of mandibular and medial retropharyngeal lymph node metastasis in dogs with oral and nasal cancer. Vet Comp Oncol. 2018;16(4):562-570.
Kneissl S, Probst A. Magnetic resonance imaging features of presumed normal head and neck lymph nodes in dogs. Vet Radiol Ultrasound. 2006;47(6):538-541.
Patnaik AK, Lieberman PH, Erlandson RA, Liu SK. Canine sinonasal skeletal neoplasms: chondrosarcomas and osteosarcomas. Vet Pathol. 1984;21(5):475-482.
Koyasu S, Tsuji Y, Harada H, et al. Evaluation of tumor-associated stroma and its relationship with tumor hypoxia using dynamic contrast-enhanced CT and 18F Misonidazole PET in murine tumor models. Radiology. 2016;278(3):734-741.
Qi Q, Yeung TPC, Lee TY, et al. Evaluation of CT perfusion biomarkers of tumor hypoxia. PLoS One. 2016;11(4):1-11.
le Grange F, Cassoni AM, Seddon BM. Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma. Eur J Surg Oncol. 2014;40(4):394-401.
Haas RL, van Beek S, Betgen A, et al. Substantial volume changes and plan adaptations during preoperative radiation therapy in extremity soft tissue sarcoma patients. Pract Radiat Oncol. 2019;9(2):115-122.
Hermans R, Meijerink M, van den Bogaert W, Rijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(5):1351-1356.
Lawrence JA, Forrest LJ, Turek MM, et al. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy. Vet Radiol Ultrasound. 2010;51(5):561-570.
Hirata E, Sahai E. Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med. 2017;7(7):1-14.
Tubiana M. Tumor cell proliferation kinetics and tumor growth rate. Acta Oncol. 1989;28:113-121.
Tuntiyatorn L, Fusuwankaya E, Sawangsilpa T, Bhongmakapat T. CT perfusion in predicting treatment response of nasopharyngeal carcinoma. J Med Assoc Thai. 2014;97(3):333-341.
Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji SK. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? Am J Neuroradiol. 2007;28(2):328-334.
Bisdas S, Rumboldt Z, Surlan-Popovic K, et al. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. Am J Neuroradiol. 2010;31(3):576-581.
Bisdas S, Nguyen SA, Anand SK, Glavina G, Day T, Rumboldt Z. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009;73(5):1313-1318.
Truong MT, Saito N, Ozonoff A, et al. Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy. Am J Neuroradiol. 2011;32(7):1195-1201.
Surlan-Popovic K, Bisdas S, Rumboldt Z, Koh TS, Strojan P. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. Am J Neuroradiol. 2010;31(3):570-575.
Chen C, Kang Q, Wei Q, et al. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma. Abdom Radiol. 2017;42(5):1464-1471.
SK E, Ramesh D, Kailasanathan N. The role of CT perfusion parameters in grading of brain gliomas in correlation with histopathology. Int J Contemp Med Res. 2017;4(2):540-544.
Wang J, Tang Z, Wang S, et al. Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions. Oncol Lett. 2016;11(5):3342-3348.
Sun ZQ, Cheng XF, Ge YX, et al. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma. J Xray Sci Technol. 2015;23(6):737-744.
Maarouf R, Sakr H. A potential role of CT perfusion parameters in grading of brain gliomas. Egypt J Radiol Nucl Med. 2015;46(4):1119-1128.
Smolarz BM, Pihno A, Lehnert NC, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol. 2007;42(3):172-179.
Li JP, Feng GL, Li DQ, et al. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model. Hepatobiliary Pancreat Dis Int. 2016;15(6):612-618.
Thaiss WM, Kaufmann S, Kloth C, Nikolaou K, Bösmüller H, Horger M. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy dynamic contrast enhanced CT. Eur J Radiol. 2016;85(11):2036-2041.
Trojanowska A, Trojanowski P, Bisdas S, et al. Squamous cell cancer of hypopharynx and larynx – evaluation of metastatic nodal disease based on computed tomography perfusion studies. Eur J Radiol. 2012;81(5):1034-1039.
Mander K, Finnie J. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance. Aust Vet J. 2018;96:371-378.
Ng CS, Wei W, Ghosh P, Anderson E, Herron DH, Chandler AG. Observer variability in CT perfusion parameters in primary and metastatic tumors in the lung. Technol Cancer Res Treat. 2018;17:1-9.
